Martin O. Bergö

9.3k total citations · 3 hit papers
106 papers, 6.8k citations indexed

About

Martin O. Bergö is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Martin O. Bergö has authored 106 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 20 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Martin O. Bergö's work include RNA Research and Splicing (20 papers), Protein Kinase Regulation and GTPase Signaling (16 papers) and Nuclear Structure and Function (15 papers). Martin O. Bergö is often cited by papers focused on RNA Research and Splicing (20 papers), Protein Kinase Regulation and GTPase Signaling (16 papers) and Nuclear Structure and Function (15 papers). Martin O. Bergö collaborates with scholars based in Sweden, United States and China. Martin O. Bergö's co-authors include Stephen G. Young, Mohamed X. Ibrahim, Volkan I. Sayin, Per Lindahl, Jonas A. Nilsson, Patrick J. Casey, Clotilde Wiel, Erik Larsson, Thomas Olivecrona and Christin Karlsson and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Martin O. Bergö

104 papers receiving 6.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antioxidants Accelerate Lung Cancer Progression in Mice

2014 656 citations Volkan I. Sayin, Mohamed X. Ibrahim et al. profile →
Antioxidants can increase melanoma metastasis in mice

2015 493 citations Mohamed X. Ibrahim, Clotilde Wiel et al. profile →
BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis

2019 427 citations Clotilde Wiel, Mohamed X. Ibrahim et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin O. Bergö Sweden	41	5.0k	947	927	889	629	106	6.8k
Lih‐Ling Lin United States	29	3.8k 0.8×	743 0.8×	691 0.7×	645 0.7×	756 1.2×	50	6.0k
Uwe Knippschild Germany	40	3.5k 0.7×	1.5k 1.6×	714 0.8×	657 0.7×	874 1.4×	134	6.0k
Cathy Tournier United Kingdom	36	4.4k 0.9×	1.1k 1.2×	911 1.0×	725 0.8×	353 0.6×	59	6.1k
Xianjun Fang United States	44	5.2k 1.0×	1.1k 1.2×	1.3k 1.4×	984 1.1×	531 0.8×	88	6.9k
Deepak Nijhawan United States	19	6.8k 1.4×	1.4k 1.5×	955 1.0×	749 0.8×	495 0.8×	28	9.1k
Damu Tang Canada	43	3.8k 0.8×	1.5k 1.6×	1.3k 1.4×	753 0.8×	322 0.5×	132	6.0k
Jongsun Park South Korea	35	4.0k 0.8×	591 0.6×	632 0.7×	445 0.5×	339 0.5×	126	5.7k
Yongjun Dang China	33	3.3k 0.7×	1.1k 1.1×	724 0.8×	496 0.6×	243 0.4×	101	5.2k
John P. Vaillancourt Canada	19	6.4k 1.3×	1.2k 1.3×	731 0.8×	941 1.1×	755 1.2×	24	8.3k
Nathalie Andrieu‐Abadie France	36	3.1k 0.6×	724 0.8×	334 0.4×	725 0.8×	710 1.1×	85	4.5k

Countries citing papers authored by Martin O. Bergö

Since Specialization

Citations

This map shows the geographic impact of Martin O. Bergö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin O. Bergö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin O. Bergö more than expected).

Fields of papers citing papers by Martin O. Bergö

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin O. Bergö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin O. Bergö. The network helps show where Martin O. Bergö may publish in the future.

Co-authorship network of co-authors of Martin O. Bergö

This figure shows the co-authorship network connecting the top 25 collaborators of Martin O. Bergö. A scholar is included among the top collaborators of Martin O. Bergö based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin O. Bergö. Martin O. Bergö is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akula, Murali K., Lieselotte Vande Walle, Mozes Sze, et al.. (2025). Pyrin inflammasome-driven erosive arthritis caused by unprenylated RHO GTPase signaling. EMBO Molecular Medicine. 17(10). 2691–2712.

Cisowski, Jarosław, Ahmed E. El Zowalaty, Sama I. Sayin, et al.. (2025). BRAF inhibition increases TGFβ2 production and stimulates metastasis in mice with endogenous BRAF ^V600E -induced hepatocellular carcinoma. Proceedings of the National Academy of Sciences. 122(45). e2503044122–e2503044122.

Lu, Wen, Yong Tang, Clotilde Wiel, et al.. (2023). SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity. Oncogene. 42(27). 2183–2194. 8 indexed citations

Wang, Ting, Yongqiang Dong, Zhiqiang Huang, et al.. (2023). Antioxidants stimulate BACH1-dependent tumor angiogenesis. Journal of Clinical Investigation. 133(20). 26 indexed citations

Maqdasy, Salwan, Simon Lecoutre, Scott Frendo‐Cumbo, et al.. (2022). Impaired phosphocreatine metabolism in white adipocytes promotes inflammation. Nature Metabolism. 4(2). 190–202. 35 indexed citations

Kerr, Alastair G., Na Wang, Kelvin H. M. Kwok, et al.. (2022). The long noncoding RNA ADIPINT regulates human adipocyte metabolism via pyruvate carboxylase. Nature Communications. 13(1). 2958–2958. 22 indexed citations

Wiel, Clotilde, Stephan Meinke, Mohammad H. Forouzanfar, et al.. (2021). Short-term IL-15 priming leaves a long-lasting signalling imprint in mouse NK cells independently of a metabolic switch. Life Science Alliance. 4(4). e202000723–e202000723. 10 indexed citations

Chen, Xue, Haidong Yao, Muhammad Kashif, et al.. (2021). A small-molecule ICMT inhibitor delays senescence of Hutchinson-Gilford progeria syndrome cells. eLife. 10. 19 indexed citations

Carlsson, Therese, Mikael Montelius, Jukka Kero, et al.. (2021). Tissue architecture delineates field cancerization in BRAFV600E-induced tumor development. Disease Models & Mechanisms. 15(2). 3 indexed citations

10.

Petrus, Paul, Simon Lecoutre, Lucile Dollet, et al.. (2019). Glutamine Links Obesity to Inflammation in Human White Adipose Tissue. Cell Metabolism. 31(2). 375–390.e11. 173 indexed citations

11.

Dalin, Martin G., Pär G. Engström, Per Unneberg, et al.. (2016). Massive parallel sequencing questions the pathogenic role of missense variants in dilated cardiomyopathy. International Journal of Cardiology. 228. 742–748. 16 indexed citations

12.

Ibrahim, Mohamed X., Volkan I. Sayin, Murali K. Akula, et al.. (2013). Targeting Isoprenylcysteine Methylation Ameliorates Disease in a Mouse Model of Progeria. Science. 340(6138). 1330–1333. 85 indexed citations

13.

Ibrahim, Mohamed X., Björn Redfors, David Pazooki, et al.. (2012). Targeting filamin A reduces K-RAS–induced lung adenocarcinomas and endothelial response to tumor growth in mice. Molecular Cancer. 11(1). 50–50. 44 indexed citations

14.

Liu, Meng, Anna-Karin Sjögren, Christin Karlsson, et al.. (2010). Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer. Proceedings of the National Academy of Sciences. 107(14). 6471–6476. 86 indexed citations

15.

Sjögren, Anna-Karin, Karin Andersson, Meng Liu, et al.. (2007). GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS–induced lung cancer. Journal of Clinical Investigation. 117(5). 1294–1304. 85 indexed citations

16.

Wahlström, Annika, Briony A. Cutts, Christin Karlsson, et al.. (2006). Rce1 deficiency accelerates the development of K-RAS–induced myeloproliferative disease. Blood. 109(2). 763–768. 49 indexed citations

17.

Yang, Shao H., Martin O. Bergö, Julia I. Toth, et al.. (2005). Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson–Gilford progeria syndrome mutation. Proceedings of the National Academy of Sciences. 102(29). 10291–10296. 240 indexed citations

18.

Winter-Vann, Ann M., Rudi Baron, Waihay J. Wong, et al.. (2005). A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells. Proceedings of the National Academy of Sciences. 102(12). 4336–4341. 154 indexed citations

19.

Bergö, Martin O., Bryant J. Gavino, Christine Hong, et al.. (2004). Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. Journal of Clinical Investigation. 113(4). 539–550. 135 indexed citations

20.

Olivecrona, Thomas, Martin O. Bergö, Magnus Hultin, & Gunilla Olivecrona. (1995). Nutritional regulation of lipoprotein lipase.. PubMed. 11 Suppl G. 73G–78G. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact